Chryseobacterium treverense sp. nov., isolated from a human clinical source

• DOI: 10.1099/ijs.0.017327-0
• Publication Date: 2009-11-03T22:56:16Z
• Authors: A. F. Yassin; H. Hupfer; C. Siering; H.-J. Busse
• Keywords: Chryseobacterium

A yellow-pigmented, Gram-reaction-negative bacterium isolated from a human clinical source was investigated using polyphasic approach in order to clarify its taxonomic status. Comparative 16S rRNA gene sequence analysis showed that the new isolate constituted distinct phyletic line within genus Chryseobacterium, displaying >2.8 % divergence with recognized species of this genus. The generic assignment confirmed by chemotaxonomic data which revealed fatty acid profile consisting straight-chain saturated, monounsaturated and branched-chain acids iso-/anteiso-types as well 3-hydroxylated acids; menaquinone six isoprene units (MK-6) predominant respiratory quinone sym-homospermidine polyamine. novel could be distinguished other members Chryseobacterium set biochemical properties. On basis phenotypic phylogenetic evidence, it is proposed represents for name treverense sp. nov. proposed. type strain IMMIB L-1519(T) (=DSM 22251(T)=CCUG 57657(T)).